Tango Therapeutics, Inc. (TNGX) Stock Price

TNGXStock

$24.77+255.22%52W

Market Cap$4.18B

P/E—

PEG Ratio—

Div yield—

Beta1.17

TNGX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)86.26%

Price vs S&P 500 (4W)-11.08%

VGM Score57.55

Book Value / Share (Quarterly)$2.72

P/TBV (Annual)3.08x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)35.89%

Cash Flow / Share (Quarterly)$-0.99

Price vs S&P 500 (YTD)164.68%

Net Profit Margin (TTM)-151.15%

EPS (TTM)$-0.83

10-Day Avg Trading Volume2.13M

EPS Excl Extra (TTM)$-0.83

EPS (Annual)$-0.87

ROI (Annual)-65.15%

Net Profit Margin (5Y Avg)-268.70%

Cash / Share (Quarterly)$2.63

Revenue Growth QoQ (YoY)363.61%

ROA (Last FY)-41.23%

Revenue Growth TTM (YoY)39.04%

EBITD / Share (TTM)$-0.92

ROE (5Y Avg)-33.14%

Operating Margin (TTM)-165.91%

Cash Flow / Share (Annual)$-1.22

P/B Ratio11.07x

P/B Ratio (Quarterly)7.62x

Net Income / Employee (Annual)$-741,600

EV / Revenue (TTM)62.80x

ROA (TTM)-33.44%

EPS Incl Extra (Annual)$-0.87

Current Ratio (Annual)7.00x

Quick Ratio (Quarterly)26.51x

3-Month Avg Trading Volume3.56M

52-Week Price Return255.22%

Revenue / Employee (TTM)$416,000

Tangible BV / Share (Quarterly)$2.72

P/S Ratio (Annual)69.47x

Asset Turnover (Annual)0.13x

52-Week High$34.39

Operating Margin (5Y Avg)-288.19%

EPS Excl Extra (Annual)$-0.87

26-Week Price Return97.50%

Quick Ratio (Annual)6.78x

13-Week Price Return13.37%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)27.38x

Enterprise Value$4.18B

Asset Turnover (TTM)0.26x

Revenue / Employee (Annual)$455,400

Pretax Margin (Annual)-162.85%

Cash / Share (Annual)$2.39

3-Month Return Std Dev127.17%

Net Income / Employee (TTM)$-782,700

ROE (Last FY)-65.15%

EPS Basic Excl Extra (Annual)$-0.87

Receivables Turnover (TTM)36.53x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.83

Receivables Turnover (Annual)12.43x

ROI (TTM)-41.54%

P/S Ratio (TTM)65.17x

Pretax Margin (5Y Avg)-268.32%

Revenue / Share (Annual)$0.54

Tangible BV / Share (Annual)$2.83

Price vs S&P 500 (52W)236.91%

Year-to-Date Return176.64%

5-Day Price Return-3.66%

EPS Normalized (Annual)$-0.87

ROA (5Y Avg)-20.59%

Net Profit Margin (Annual)-162.85%

Month-to-Date Return-9.82%

Cash Flow / Share (TTM)$-1.08

EBITD / Share (Annual)$-0.94

Operating Margin (Annual)-178.39%

ROI (5Y Avg)-33.14%

EPS Basic Excl Extra (TTM)$-0.83

P/TBV (Quarterly)2.78x

P/B Ratio (Annual)1.67x

Pretax Margin (TTM)-150.99%

Book Value / Share (Annual)$1.84

Price vs S&P 500 (13W)10.57%

Beta1.17x

Revenue / Share (TTM)$0.40

ROE (TTM)-41.54%

52-Week Low$6.25

vGradeF

gGradeA

mGradeB

vgmGradeC

TNGX Earnings Surprise History

Q2 25-0.35est. -0.34

Q3 250.13est. -0.01

Q4 25-0.29est. -0.33

Q1 26-0.32est. -0.31

Q2 26-0.37est. -0.32

TNGX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.28

4.11

4.33

4.32

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
TNGXTango Therapeutics, Inc.	F	A	B	$24.77
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Tango Therapeutics, Inc.

Tango Therapeutics is a precision oncology company developing novel targeted therapies for cancer. The company is advancing PRMT5 inhibitors including TNG462 for non-CNS cancers such as pancreatic and lung cancer, and TNG456, a brain-penetrant inhibitor for CNS cancers including glioblastoma. The pipeline also targets CoREST pathways.